SCOT Study Leadership
Keith Sullivan, MD
Keith Sullivan, MD, is the James B. Wyngaarden Professor of Medicine and recently chief of the combined Division of Medical Oncology and Transplantation at Duke University Medical Center.
Dr. Sullivan came to Duke in 1999 from the Fred Hutchinson Cancer Center and the University of Washington in Seattle, where he was a member of the Clinical Research Division and head of the Long-Term Follow-up Program. He is a renowned expert in blood and marrow transplantation and is widely published on the subject. His research focuses on the late effects of high-dose chemotherapy and stem cell transplantation, graft-versus-host disease, and the use of transplantation as a treatment for sickle cell and autoimmune diseases.
Dr. Sullivan has been a member of the board of directors for the American Society of Hematology and the Foundation for the Accreditation of Hematopoietic Cell Therapy and was the president and a founding member of the American Society for Blood and Marrow Transplantation. He is an electee of the Association for American Physicians and a Fellow of the American Association for the Advancement of Science. He currently serves on the editorial board of several publications, including Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, Blood Reviews and Hem/Onc Today.
Dr. Sullivan has published more than 400 research articles and was recently recognized as an ISI Highly Cited Researcher, Clinical Medicine Category, by the Institute for Scientific Information.